TCL Archive New Breast Cancer Trials to Include Pre Vs. Post Operative Chemotherapy, CSF Pilot Studies August 5, 1988
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013